Patient-derived Xenograft (PDX) Models Market, Global Outlook and Forecast 2022-2028

May 2022 | 107 pages | ID: P34F63D66FA9EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Patient-derived Xenograft (PDX) Models in Global, including the following market information:

Global Patient-derived Xenograft (PDX) Models Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Patient-derived Xenograft (PDX) Models market was valued at 341.2 million in 2021 and is projected to reach US$ 591.4 million by 2028, at a CAGR of 8.2% during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Mouse Model Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Patient-derived Xenograft (PDX) Models include Crown Bioscience, Champions Oncology, Wuxi Apptec, The Jackson Laboratory, EPO Berlin-Buch, Oncodesign, Xentech, Envigo and Charles River Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Patient-derived Xenograft (PDX) Models companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Patient-derived Xenograft (PDX) Models Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Patient-derived Xenograft (PDX) Models Market Segment Percentages, by Type, 2021 (%)

• Mouse Model
• Rat Model

Global Patient-derived Xenograft (PDX) Models Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Patient-derived Xenograft (PDX) Models Market Segment Percentages, by Application, 2021 (%)

• Preclinical Drug development
• Biomarker Analysis

Global Patient-derived Xenograft (PDX) Models Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Patient-derived Xenograft (PDX) Models Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Patient-derived Xenograft (PDX) Models revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Patient-derived Xenograft (PDX) Models revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Crown Bioscience
• Champions Oncology
• Wuxi Apptec
• The Jackson Laboratory
• EPO Berlin-Buch
• Oncodesign
• Xentech
• Envigo
• Charles River Laboratories
• Pharmatest Services
• Urosphere
• MEDICILON
• Horizon Discovery
• Shanghai Model Organisms Center
• GemPharmatech
• LIDE Biotech

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Patient-derived Xenograft (PDX) Models Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Patient-derived Xenograft (PDX) Models Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PATIENT-DERIVED XENOGRAFT (PDX) MODELS OVERALL MARKET SIZE

2.1 Global Patient-derived Xenograft (PDX) Models Market Size: 2021 VS 2028
2.2 Global Patient-derived Xenograft (PDX) Models Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Patient-derived Xenograft (PDX) Models Players in Global Market
3.2 Top Global Patient-derived Xenograft (PDX) Models Companies Ranked by Revenue
3.3 Global Patient-derived Xenograft (PDX) Models Revenue by Companies
3.4 Top 3 and Top 5 Patient-derived Xenograft (PDX) Models Companies in Global Market, by Revenue in 2021
3.5 Global Companies Patient-derived Xenograft (PDX) Models Product Type
3.6 Tier 1, Tier 2 and Tier 3 Patient-derived Xenograft (PDX) Models Players in Global Market
  3.6.1 List of Global Tier 1 Patient-derived Xenograft (PDX) Models Companies
  3.6.2 List of Global Tier 2 and Tier 3 Patient-derived Xenograft (PDX) Models Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Patient-derived Xenograft (PDX) Models Market Size Markets, 2021 & 2028
  4.1.2 Mouse Model
  4.1.3 Rat Model
4.2 By Type - Global Patient-derived Xenograft (PDX) Models Revenue & Forecasts
  4.2.1 By Type - Global Patient-derived Xenograft (PDX) Models Revenue, 2017-2022
  4.2.2 By Type - Global Patient-derived Xenograft (PDX) Models Revenue, 2023-2028
  4.2.3 By Type - Global Patient-derived Xenograft (PDX) Models Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Patient-derived Xenograft (PDX) Models Market Size, 2021 & 2028
  5.1.2 Preclinical Drug development
  5.1.3 Biomarker Analysis
5.2 By Application - Global Patient-derived Xenograft (PDX) Models Revenue & Forecasts
  5.2.1 By Application - Global Patient-derived Xenograft (PDX) Models Revenue, 2017-2022
  5.2.2 By Application - Global Patient-derived Xenograft (PDX) Models Revenue, 2023-2028
  5.2.3 By Application - Global Patient-derived Xenograft (PDX) Models Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Patient-derived Xenograft (PDX) Models Market Size, 2021 & 2028
6.2 By Region - Global Patient-derived Xenograft (PDX) Models Revenue & Forecasts
  6.2.1 By Region - Global Patient-derived Xenograft (PDX) Models Revenue, 2017-2022
  6.2.2 By Region - Global Patient-derived Xenograft (PDX) Models Revenue, 2023-2028
  6.2.3 By Region - Global Patient-derived Xenograft (PDX) Models Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Patient-derived Xenograft (PDX) Models Revenue, 2017-2028
  6.3.2 US Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.3.3 Canada Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.3.4 Mexico Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Patient-derived Xenograft (PDX) Models Revenue, 2017-2028
  6.4.2 Germany Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.4.3 France Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.4.4 U.K. Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.4.5 Italy Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.4.6 Russia Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.4.7 Nordic Countries Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.4.8 Benelux Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Patient-derived Xenograft (PDX) Models Revenue, 2017-2028
  6.5.2 China Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.5.3 Japan Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.5.4 South Korea Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.5.5 Southeast Asia Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.5.6 India Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Patient-derived Xenograft (PDX) Models Revenue, 2017-2028
  6.6.2 Brazil Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.6.3 Argentina Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue, 2017-2028
  6.7.2 Turkey Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.7.3 Israel Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.7.4 Saudi Arabia Patient-derived Xenograft (PDX) Models Market Size, 2017-2028
  6.7.5 UAE Patient-derived Xenograft (PDX) Models Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Crown Bioscience
  7.1.1 Crown Bioscience Corporate Summary
  7.1.2 Crown Bioscience Business Overview
  7.1.3 Crown Bioscience Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.1.4 Crown Bioscience Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.1.5 Crown Bioscience Key News
7.2 Champions Oncology
  7.2.1 Champions Oncology Corporate Summary
  7.2.2 Champions Oncology Business Overview
  7.2.3 Champions Oncology Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.2.4 Champions Oncology Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.2.5 Champions Oncology Key News
7.3 Wuxi Apptec
  7.3.1 Wuxi Apptec Corporate Summary
  7.3.2 Wuxi Apptec Business Overview
  7.3.3 Wuxi Apptec Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.3.4 Wuxi Apptec Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.3.5 Wuxi Apptec Key News
7.4 The Jackson Laboratory
  7.4.1 The Jackson Laboratory Corporate Summary
  7.4.2 The Jackson Laboratory Business Overview
  7.4.3 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.4.4 The Jackson Laboratory Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.4.5 The Jackson Laboratory Key News
7.5 EPO Berlin-Buch
  7.5.1 EPO Berlin-Buch Corporate Summary
  7.5.2 EPO Berlin-Buch Business Overview
  7.5.3 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.5.4 EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.5.5 EPO Berlin-Buch Key News
7.6 Oncodesign
  7.6.1 Oncodesign Corporate Summary
  7.6.2 Oncodesign Business Overview
  7.6.3 Oncodesign Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.6.4 Oncodesign Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.6.5 Oncodesign Key News
7.7 Xentech
  7.7.1 Xentech Corporate Summary
  7.7.2 Xentech Business Overview
  7.7.3 Xentech Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.7.4 Xentech Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.7.5 Xentech Key News
7.8 Envigo
  7.8.1 Envigo Corporate Summary
  7.8.2 Envigo Business Overview
  7.8.3 Envigo Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.8.4 Envigo Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.8.5 Envigo Key News
7.9 Charles River Laboratories
  7.9.1 Charles River Laboratories Corporate Summary
  7.9.2 Charles River Laboratories Business Overview
  7.9.3 Charles River Laboratories Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.9.4 Charles River Laboratories Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.9.5 Charles River Laboratories Key News
7.10 Pharmatest Services
  7.10.1 Pharmatest Services Corporate Summary
  7.10.2 Pharmatest Services Business Overview
  7.10.3 Pharmatest Services Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.10.4 Pharmatest Services Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.10.5 Pharmatest Services Key News
7.11 Urosphere
  7.11.1 Urosphere Corporate Summary
  7.11.2 Urosphere Business Overview
  7.11.3 Urosphere Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.11.4 Urosphere Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.11.5 Urosphere Key News
7.12 MEDICILON
  7.12.1 MEDICILON Corporate Summary
  7.12.2 MEDICILON Business Overview
  7.12.3 MEDICILON Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.12.4 MEDICILON Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.12.5 MEDICILON Key News
7.13 Horizon Discovery
  7.13.1 Horizon Discovery Corporate Summary
  7.13.2 Horizon Discovery Business Overview
  7.13.3 Horizon Discovery Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.13.4 Horizon Discovery Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.13.5 Horizon Discovery Key News
7.14 Shanghai Model Organisms Center
  7.14.1 Shanghai Model Organisms Center Corporate Summary
  7.14.2 Shanghai Model Organisms Center Business Overview
  7.14.3 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.14.4 Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.14.5 Shanghai Model Organisms Center Key News
7.15 GemPharmatech
  7.15.1 GemPharmatech Corporate Summary
  7.15.2 GemPharmatech Business Overview
  7.15.3 GemPharmatech Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.15.4 GemPharmatech Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.15.5 GemPharmatech Key News
7.16 LIDE Biotech
  7.16.1 LIDE Biotech Corporate Summary
  7.16.2 LIDE Biotech Business Overview
  7.16.3 LIDE Biotech Patient-derived Xenograft (PDX) Models Major Product Offerings
  7.16.4 LIDE Biotech Patient-derived Xenograft (PDX) Models Revenue in Global Market (2017-2022)
  7.16.5 LIDE Biotech Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Patient-derived Xenograft (PDX) Models Market Opportunities & Trends in Global Market
Table 2. Patient-derived Xenograft (PDX) Models Market Drivers in Global Market
Table 3. Patient-derived Xenograft (PDX) Models Market Restraints in Global Market
Table 4. Key Players of Patient-derived Xenograft (PDX) Models in Global Market
Table 5. Top Patient-derived Xenograft (PDX) Models Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Patient-derived Xenograft (PDX) Models Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Patient-derived Xenograft (PDX) Models Revenue Share by Companies, 2017-2022
Table 8. Global Companies Patient-derived Xenograft (PDX) Models Product Type
Table 9. List of Global Tier 1 Patient-derived Xenograft (PDX) Models Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Patient-derived Xenograft (PDX) Models Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Patient-derived Xenograft (PDX) Models Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Patient-derived Xenograft (PDX) Models Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Patient-derived Xenograft (PDX) Models Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Patient-derived Xenograft (PDX) Models Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2023-2028
Table 30. Crown Bioscience Corporate Summary
Table 31. Crown Bioscience Patient-derived Xenograft (PDX) Models Product Offerings
Table 32. Crown Bioscience Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 33. Champions Oncology Corporate Summary
Table 34. Champions Oncology Patient-derived Xenograft (PDX) Models Product Offerings
Table 35. Champions Oncology Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 36. Wuxi Apptec Corporate Summary
Table 37. Wuxi Apptec Patient-derived Xenograft (PDX) Models Product Offerings
Table 38. Wuxi Apptec Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 39. The Jackson Laboratory Corporate Summary
Table 40. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Product Offerings
Table 41. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 42. EPO Berlin-Buch Corporate Summary
Table 43. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Product Offerings
Table 44. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 45. Oncodesign Corporate Summary
Table 46. Oncodesign Patient-derived Xenograft (PDX) Models Product Offerings
Table 47. Oncodesign Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 48. Xentech Corporate Summary
Table 49. Xentech Patient-derived Xenograft (PDX) Models Product Offerings
Table 50. Xentech Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 51. Envigo Corporate Summary
Table 52. Envigo Patient-derived Xenograft (PDX) Models Product Offerings
Table 53. Envigo Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 54. Charles River Laboratories Corporate Summary
Table 55. Charles River Laboratories Patient-derived Xenograft (PDX) Models Product Offerings
Table 56. Charles River Laboratories Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 57. Pharmatest Services Corporate Summary
Table 58. Pharmatest Services Patient-derived Xenograft (PDX) Models Product Offerings
Table 59. Pharmatest Services Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 60. Urosphere Corporate Summary
Table 61. Urosphere Patient-derived Xenograft (PDX) Models Product Offerings
Table 62. Urosphere Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 63. MEDICILON Corporate Summary
Table 64. MEDICILON Patient-derived Xenograft (PDX) Models Product Offerings
Table 65. MEDICILON Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 66. Horizon Discovery Corporate Summary
Table 67. Horizon Discovery Patient-derived Xenograft (PDX) Models Product Offerings
Table 68. Horizon Discovery Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 69. Shanghai Model Organisms Center Corporate Summary
Table 70. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Product Offerings
Table 71. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 72. GemPharmatech Corporate Summary
Table 73. GemPharmatech Patient-derived Xenograft (PDX) Models Product Offerings
Table 74. GemPharmatech Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)
Table 75. LIDE Biotech Corporate Summary
Table 76. LIDE Biotech Patient-derived Xenograft (PDX) Models Product Offerings
Table 77. LIDE Biotech Patient-derived Xenograft (PDX) Models Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Patient-derived Xenograft (PDX) Models Segment by Type in 2021
Figure 2. Patient-derived Xenograft (PDX) Models Segment by Application in 2021
Figure 3. Global Patient-derived Xenograft (PDX) Models Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Patient-derived Xenograft (PDX) Models Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Patient-derived Xenograft (PDX) Models Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Patient-derived Xenograft (PDX) Models Revenue in 2021
Figure 8. By Type - Global Patient-derived Xenograft (PDX) Models Revenue Market Share, 2017-2028
Figure 9. By Application - Global Patient-derived Xenograft (PDX) Models Revenue Market Share, 2017-2028
Figure 10. By Region - Global Patient-derived Xenograft (PDX) Models Revenue Market Share, 2017-2028
Figure 11. By Country - North America Patient-derived Xenograft (PDX) Models Revenue Market Share, 2017-2028
Figure 12. US Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Patient-derived Xenograft (PDX) Models Revenue Market Share, 2017-2028
Figure 16. Germany Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 17. France Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Patient-derived Xenograft (PDX) Models Revenue Market Share, 2017-2028
Figure 24. China Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 28. India Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Patient-derived Xenograft (PDX) Models Revenue Market Share, 2017-2028
Figure 30. Brazil Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Patient-derived Xenograft (PDX) Models Revenue Market Share, 2017-2028
Figure 33. Turkey Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Patient-derived Xenograft (PDX) Models Revenue, (US$, Mn), 2017-2028
Figure 37. Crown Bioscience Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Champions Oncology Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Wuxi Apptec Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. The Jackson Laboratory Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. EPO Berlin-Buch Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Oncodesign Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Xentech Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Envigo Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Charles River Laboratories Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pharmatest Services Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Urosphere Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. MEDICILON Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Horizon Discovery Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Shanghai Model Organisms Center Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. GemPharmatech Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. LIDE Biotech Patient-derived Xenograft (PDX) Models Revenue Year Over Year Growth (US$, Mn) & (2017-2022)